Abbvie Inc. vs McKesson Corporation
ABBV vs MCK — side-by-side comparison from reported financials. ABBV leads 5, MCK leads 7 of 12 comparable metrics.
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
McKesson Corporation
MCK · Healthcare
$938.84+0.92%Solid
| Metric | ABBV | MCK |
|---|---|---|
| Price | $276.43 | $938.84 |
| Market cap | $488B | $109B |
| Revenue (TTM) | $64.4B | $411B |
| Revenue growth | +1.8% | +13.4% |
| Net margin | 9.8% | 1.1% |
| Free cash flow | $18.2B | $6.42B |
| Net cash (debt) | ($56.2B) | ($4.81B) |
| 1-year price return | +19.8% | +23.9% |
| P/E | 77.4 | 23.8 |
| P/E vs own history (cheap-side %) | 23% | 59% |
| Dividend yield | 2.45% | 0.36% |
| Return on equity | 96% | 39% |
| Altman Z-score | 2.33 | 2.25 |
| CV checks passed | 9 of 11 | 11 of 11 |
| Employees | 57,000 | 43,000 |
Full résumé-style profiles: ABBV CV · MCK CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.